ArticleInternational journal of hematology2020

Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group.

Hiroki Yamaguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.